Kyverna Therapeutics(KYTX) - 2025 Q4 - Annual Results

FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 08, 2026 Kyverna Therapeutics, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-41947 83-1365441 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Securities registered pursuant to Section 12(b) of the Act: ...